Laserfiche WebLink
use disorder so that they might be given the option of referral to a proper <br />treatment program. <br />3. Training for obstetricians or other healthcare personnel that work with pregnant <br />women and their families regarding treatment of OUD and any co-occurring <br />SUD/MH issues. <br />4. Other measures to address Neonatal Abstinence Syndrome, including <br />prevention, education, and treatment of OUD and any co-occurring SUD/MH <br />issues. <br />5. Provide training to healthcare providers that work with pregnant or parenting <br />women on best practices for compliance with federal requirements that children <br />born with Neonatal Abstinence Syndrome get referred to appropriate services <br />and receive a plan of safe care. <br />6. Child and family support for parenting women with OUD and any co-occurring <br />SUD/MH issues. <br />7. Enhanced family supports and childcare services for parents with OUD and any <br />co-occurring SUD/MH issues. <br />8. Provide enhanced support for children and family members suffering trauma as <br />a result of addiction in the family; and offer trauma -informed behavioral health <br />treatment for adverse childhood events. <br />9. Offer home-based wrap-around services to persons with OUD and any co- <br />occurring SUD/MH issues, including but not limited to parent skills training. <br />10. Support for Children's Services — Fund additional positions and services, <br />including supportive housing and other residential services, relating to children <br />being removed from the home and/or placed in foster care due to custodial <br />opioid use. <br />11. Provision of education and psychosocial support services to children born with <br />Neonatal Abstinance Syndrome. <br />12. Support family and baby reunification in recovery housing. <br />PART TWO: PREVENTION <br />6 <br />